The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Effects of Stimulants on the Continuous Performance Test (CPT): Implications for CPT Use and Interpretation
Abstract
An increasing number of treatment plans for individuals with attention-deficit/hyperactivity disorder (ADHD), as well as other disorders, include stimulant medication. The purpose of this study was to investigate the effects of stimulant medications on attention and impulsivity as measured by continuous performance tests (CPTs). The effect of other stimulants (e.g., caffeine, nicotine) on CPT performance was examined as well. Although various versions of the CPT were used in the studies reviewed, the research supports improvements in CPT performance with stimulant treatment. Implications for the use of CPTs in evaluating the effects of medications on attention are discussed. Also presented are implications for control of common substances like nicotine or caffeine when CPT is used and interpreted as a measure of attention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A continuous performance test of brain damage
Rosvold, H. E., Mirsky, A. F., Sarason, I., Bransome, E. D., & Beck, L. H. (1956) · Journal of Consulting Psychology · doi:10.1037/h0043220 · Cited by 2,261
Losier, B. J., McGrath, P. J., & Klein, R. M. (1996) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1996.tb01494.x · Cited by 424
Nicotine effects on adults with attention-deficit/hyperactivity disorder
Levin, E. D., Conners, C. K., Sparrow, E., Hinton, S. C., Erhardt, D., Meck, W. H., Rose, J. E., & March, J. (1996) · Psychopharmacology · doi:10.1007/bf02246281 · Cited by 415
GREENHILL, L. L., HALPERIN, J. M., & ABIKOFF, H. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199905000-00011 · Cited by 268
The Dopamine Theory of Attention Deficit Hyperactivity Disorder (ADHD)
Levy, F. (1991) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048679109077746 · Cited by 234
A controlled trial of stimulant medication in children with the fragile X syndrome
Hagerman, R. J., Murphy, M. A., & Wittenberger, M. D. (1988) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320300138 · Cited by 158
Caffeine effects on learning, performance, and anxiety in normal school‐age children
BERNSTEIN, G. A., CARROLL, M. E., CROSBY, R. D., PERWIEN, A. R., GO, F. S., & BENOWITZ, N. L. (1994) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199403000-00016 · Cited by 108
Rapport, M. D., Jones, J. T., DuPaul, G. J., Kelly, K. L., Gardner, M. J., Tucker, S. B., & Shea, M. S. (1987) · Journal of Clinical Child Psychology · doi:10.1207/s15374424jccp1604_6 · Cited by 91
SOLANTO, M. V., WENDER, E. H., & BARTELL, S. S. (1997) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1997.7.123 · Cited by 58
Cited by
Reliability and validity of a computerized neurocognitive test battery, CNS vital signs
GUALTIERI, C., & JOHNSON, L. (2006) · Archives of Clinical Neuropsychology · doi:10.1016/j.acn.2006.05.007 · Cited by 873
Rubia, K., Halari, R., Cubillo, A., Mohammad, A.-M., Brammer, M., & Taylor, E. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.08.013 · Cited by 393
Effect of Melatonin on Sleep, Behavior, and Cognition in ADHD and Chronic Sleep-Onset Insomnia
VAN der HEIJDEN, K. B., SMITS, M. G., VAN SOMEREN, E. J. W., RIDDERINKHOF, K. R., & GUNNING, W. B. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000246055.76167.0d · Cited by 378
The Schizophrenia Prodrome Revisited: A Neurodevelopmental Perspective
Cornblatt, B. A., Lencz, T., Smith, C. W., Correll, C. U., Auther, A. M., & Nakayama, E. (2003) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007036 · Cited by 377
Evaluating vigilance deficits in ADHD: A meta-analysis of CPT performance.
Huang-Pollock, C. L., Karalunas, S. L., Tam, H., & Moore, A. N. (2012) · Journal of Abnormal Psychology · doi:10.1037/a0027205 · Cited by 359
The vigilance regulation model of affective disorders and ADHD
Hegerl, U., & Hensch, T. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.10.008 · Cited by 212
Heo, J.-Y., Kim, K., Fava, M., Mischoulon, D., Papakostas, G. I., Kim, M.-J., Kim, D. J., Chang, K.-A. J., Oh, Y., Yu, B.-H., et al. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.12.010 · Cited by 192
Navarra, R., Graf, R., Huang, Y., Logue, S., Comery, T., Hughes, Z., & Day, M. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.06.017 · Cited by 183
A Review of the Validity of Laboratory Cognitive Tasks Used to Assess Symptoms of ADHD
Nichols, S. L., & Waschbusch, D. A. (2004) · Child Psychiatry and Human Development · doi:10.1023/b:chud.0000020681.06865.97 · Cited by 165
Boonstra, A. M., Kooij, J. J. S., Oosterlaan, J., Sergeant, J. A., & Buitelaar, J. K. (2005) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390490515757 · Cited by 157
Impulsivity and chronic stress are associated with amphetamine-induced striatal dopamine release
Oswald, L. M., Wong, D. F., Zhou, Y., Kumar, A., Brasic, J., Alexander, M., Ye, W., Kuwabara, H., Hilton, J., & Wand, G. S. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.01.055 · Cited by 108
Agay, N., Yechiam, E., Carmel, Z., & Levkovitz, Y. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1853-4 · Cited by 101
Spencer, S. V., Hawk, L. W., Richards, J. B., Shiels, K., Pelham, W. E., & Waxmonsky, J. G. (2009) · Journal of Abnormal Child Psychology · doi:10.1007/s10802-009-9316-2 · Cited by 93
Lerner, A., & Klein, M. (2019) · Brain Communications · doi:10.1093/braincomms/fcz025 · Cited by 89
Tucha, O., Prell, S., Mecklinger, L., Bormann-Kischkel, C., Kübber, S., Linder, M., Walitza, S., & Lange, K. W. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0318-2 · Cited by 89
Tamminga, H. G. H., Reneman, L., Huizenga, H. M., & Geurts, H. M. (2016) · Psychological Medicine · doi:10.1017/s0033291716000350 · Cited by 82
Johnson, K. A., Barry, E., Bellgrove, M. A., Cox, M., Kelly, S. P., Dáibhis, A., Daly, M., Keavey, M., Watchorn, A., Fitzgerald, M., et al. (2008) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2008.01.002 · Cited by 62
Behavioral Assessment of Core ADHD Symptoms Using the QbTest
Reh, V., Schmidt, M., Lam, L., Schimmelmann, B. G., Hebebrand, J., Rief, W., & Christiansen, H. (2015) · Journal of Attention Disorders · doi:10.1177/1087054712472981 · Cited by 51
Schachar, R., Ickowicz, A., Crosbie, J., Donnelly, G. A. E., Reiz, J. L., Miceli, P. C., Harsanyi, Z., & Darke, A. C. (2008) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2007.0039 · Cited by 43
Wilson, C. A., Schade, R., & Terry, A. V. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.040 · Cited by 40
New Insights on the Effects of Methylphenidate in Attention Deficit Hyperactivity Disorder
Pitzianti, M. B., Spiridigliozzi, S., Bartolucci, E., Esposito, S., & Pasini, A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.531092 · Cited by 28
“org 3 Several studies have shown that DA and norepinephrine participate in the processes of attention and inhibition (42, 43), and low levels of these two neurotransmitters cause dysfunction in the above-mentioned processes.”
BackgroundKim, Y., Shin, M., Kim, J., Yoo, H., Cho, S., & Kim, B. (2009) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1010 · Cited by 25
Polli, F. S., Ipsen, T. H., Caballero-Puntiverio, M., Østerbøg, T. B., Aznar, S., Andreasen, J. T., & Kohlmeier, K. A. (2020) · Molecular Neurobiology · doi:10.1007/s12035-019-01854-9 · Cited by 25
Assessment of cognitive domains during treatment with OROS methylphenidate in adolescents with ADHD
Hammerness, P., Fried, R., Petty, C., Meller, B., & Biederman, J. (2014) · Child Neuropsychology · doi:10.1080/09297049.2013.790359 · Cited by 14
Pharmacological Treatment of Cognitive Dysfunction in Neuropsychiatric Disorders
Venero, C. (2015) · Cognitive Enhancement · doi:10.1016/b978-0-12-417042-1.00010-3 · Cited by 4
Metadata
- Authors
- Riccio, C. A., Waldrop, J. J. M., Reynolds, C. R., & Lowe, P.
- Venue
- The Journal of Neuropsychiatry and Clinical Neurosciences
- Published
- 2001-08
- Volume
- 13
- Issue
- 3
- Pages
- 326-335
- ISSN
- 0895-0172 (ISSN-L)
- 1545-7222
- OpenAlex
- W2103308252
- Cited by
- 218
- References
- 9
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.